mNGS for IFD in Patients With Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Hematological Malignancies
Related studies linked through entity extraction aliases.
To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
- Status
- RECRUITING
- Phase
- PHASE2
Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Acalabrutinib Maleate and Bortezomib for Patients With HLA Antibodies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Complementary and Alternative Medicine Among Patients With Hematologic Malignancies in France
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
The Effect of Relaxation Breathing Exercise on Chemotherapy Induced Nausea and Vomiting
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- EARLY_PHASE1
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
18F-Pentixafor PET in Hematologic Malignancies
- Status
- RECRUITING
- Phase
- N/A
Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Immunological Impact of a Post Cell Therapy Treatment With FLT3 Inhibitors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Observational Study for the Evaluation of Immune-mediated Endocrinological Adverse Events in Patients With Hematological Malignancies and Subjected to Treatment With Immune-checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- N/A
A Study Evaluating the Value of 68Ga-Pentixafor PET Imaging in the Staging of Hematological Tumor, and Comparing It with 18F-FDG PET/CT Imaging
- Status
- RECRUITING
- Phase
- NA
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2